Silica Aerogel Insulation: Thermal Performance, Uses and Cost Comparison

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Gel Manufacturer: Product Types, Quality Standards and Selection Guide
  • Keywords: silica for HPLC
  • Published: 2026-11-20 02:13:23
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
SBA-series mesoporous materials were first reported by researchers from the University of California at Santa Barbara, 47 which consists of a silica-based framework with extremely ordered mesoporous structure, tunable pore size, high particular surface region, and thermal stability. There are numerous silica-based mesoporous materials in the SBA family, such as SBA-1, SBA-2, SBA-3, SBA-6, SBA-7, SBA-8, SBA-11, SBA-12, SBA-14, SBA-15 and SBA-16. 47, 63, 77, 78 However, of these materials, only SBA-15 and SBA-16 are widely used in biomedical applications, while other types of MSNs such as SBA-1, 79, 80, 81 SBA-2, 82, 83 SBA-3, 84, 85 SBA-11, 86, 87 SBA-12 88 are mostly applied in the field of adsorption and catalysis. By using a triblock copolymer, Pluronic 123, as the structure-directing agent under acidic condition, SBA-15 with 2D hexagonal structure containing P6mm space-group symmetry can be synthesized. 47, 89 Compared with MCM-41, the thick pore walls (up to 9 nm) make SBA-15 more stable thermally and mechanically. Especially, the high particular surface area (~1000 m 2 g -1 ) and larger pore size (4-30 nm) of SBA-15 make it a brilliant cargo carrier to load large molecule drugs in the biomedical field. 90 Similarly, a cubic ( Im3̄m ) cage-structured SBA-16 can be obtained by utilizing Pluronic F127 as the structure-directing agent, and the surface area and stability of SBA-16 are similar to that of SBA-15. 78

Silica for Thermal Insulation: Aerogel, Fumed Silica and Microporous Materials Compared

Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
High Purity Quartz Sand: Specifications, Uses in Solar and Semiconductors, and Suppliers
Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
Li, L. et al. Multifunctional carbon-silica nanocapsules with gold core for synergistic photothermal and chemo‐cancer therapy under the advice of bimodal imaging. Adv. Funct. Mater. 26, 4252-4261 (2016). Piece CAS Google Scholar

Ultrafine Silica Powder: Particle Sizes, Specifications and Applications

What is silica (SiO₂)?

silica supply chain

What is the difference between fumed silica and precipitated silica?

silica supplier Japan Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.

What drives silica raw material prices?

amorphous vs crystalline silica Gu, T. et al. Platinum nanoparticles to enable electrodynamic therapy for effective cancer treatment. Adv. Mater. 31, 1806803 (2019). Article Google Scholar

Cite this article: Silica Raw Materials News. "What Is Silicon Dioxide? Simple Definition, Formula and Everyday Examples ." Published 2026-11-20 02:13:23. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.